☆ 4.7 Article

HnRNP A2/B1 as a potential anti-tumor target for triptolide based on a simplified thermal proteome profiling method using XGBoost

PHYTOMEDICINE (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Biochemistry & Molecular Biology

Precipitate-Supported Thermal Proteome Profiling Coupled with Deep Learning for Comprehensive Screening of Drug Target Proteins

Chengfei Ruan et al.

Summary: In this study, a new method called PSTPP was proposed, which enables unbiased and comprehensive analysis of protein-drug interactions at the proteome level by utilizing precipitate-based preprocessing and image recognition algorithm based on deep learning, thereby improving screening specificity and sensitivity.

ACS CHEMICAL BIOLOGY (2022)

添加到收藏夹

Article Medicine, Research & Experimental

Macropinocytic dextran facilitates KRAS-targeted delivery while reducing drug-induced tumor immunity depletion in pancreatic cancer

Fang Yuan et al.

Summary: Pancreatic cancer cells with high levels of macropinocytosis can be targeted using macropinocytic dextran as a delivery carrier. Conjugating triptolide with 70 kDa dextran enhances the therapeutic effects on KRAS mutant cells and preserves immune factors, reducing the impact on T cells.

THERANOSTICS (2022)

添加到收藏夹

Article Cell Biology

Characterization of a small molecule inhibitor of disulfide reductases that induces oxidative stress and lethality in lung cancer cells

Fraser D. Johnson et al.

Summary: Phenotype-based screening led to the identification of a compound called LCS3 that selectively impairs the growth of LUAD cells, induces oxidative stress, and inhibits the activity of disulfide reductases GSR and TXNRD1. The study also reveals that LCS3-sensitive LUAD cells are sensitive to the synergistic inhibition of glutathione and thioredoxin pathways. Furthermore, NQO1 loss is identified as a mechanism of LCS3 resistance through a genome-wide CRISPR knockout screen.

CELL REPORTS (2022)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Exosome-liposome hybrid nanoparticle codelivery of TP and miR497 conspicuously overcomes chemoresistant ovarian cancer

Longxia Li et al.

Summary: This study investigated the combined application of miR497 and TP in overcoming cisplatin-resistant ovarian cancer (OC) by suppressing the mTOR signaling pathway. Bioinspired hybrid nanoparticles were prepared to deliver miR497 and TP, showing efficient uptake by tumor cells and significant anticancer activity in vitro and in vivo. Mechanistically, the nanoparticles promoted dephosphorylation of the overactivated PI3K/AKT/mTOR signaling pathway and enhanced reactive oxygen species (ROS) generation and macrophage polarization. Overall, this study offers a translational strategy to overcome cisplatin-resistant OC and potentially treat other cisplatin-resistant tumors.

JOURNAL OF NANOBIOTECHNOLOGY (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

Drug Target Identification in Tissues by Thermal Proteome Profiling

Andre Mateus et al.

Summary: Drug target deconvolution is crucial for accelerating the drug discovery process by identifying drug targets and off-targets. Thermal proteome profiling (TPP) is a method that can identify intracellular targets without compound modification, and its recent developments have expanded its applications to tissue studies and protein-drug interaction research.

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2022)

添加到收藏夹

Article Chemistry, Analytical

Matrix Thermal Shift Assay for Fast Construction of Multidimensional Ligand-Target Space

Chengfei Ruan et al.

Summary: This article presents a new method called matrix thermal shift assay (mTSA) for fast and accurate deconvolution of ligand-binding targets and binding affinities at the proteome level. Compared to previous thermal shift assays, mTSA significantly improves analysis throughput while reducing costs and efforts. The method allows for simultaneous computation of statistical significance and fitting of dose-response profiles, resulting in more accurate identification of target proteins and reporting of binding affinities. Experimental results demonstrate the high screening sensitivity of mTSA and its potential for discovering potential targets.

ANALYTICAL CHEMISTRY (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Interaction of lncRNA MIR100HG with hnRNPA2B1 facilitates m6A-dependent stabilization of TCF7L2 mRNA and colorectal cancer progression

Hao Liu et al.

Summary: The study reveals that MIR100HG serves as a positive regulator of EMT in CRC, sustaining cetuximab resistance and promoting invasion and metastasis. It interacts with hnRNPA2B1 to control Wnt signaling transcriptional activity via regulation of TCF7L2 mRNA stability, forming a feedback loop that may contribute to cetuximab resistance and metastasis in CRC.

MOLECULAR CANCER (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Emerging roles of hnRNP A2B1 in cancer and inflammation

Huangru Xu et al.

Summary: Heterogeneous nuclear ribonucleoproteins (hnRNPs) are RNA-binding proteins that play important roles in various aspects of nucleic acid metabolism. hnRNP A2B1, as a core component of the hnRNP complex, has regulatory functions in inflammation and cancer progression. Understanding the biological roles of hnRNP A2B1 in cancer, immune response, and inflammation is of increasing interest.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2022)

添加到收藏夹

Article Cell Biology

Triptolide decreases tumor-associated macrophages infiltration and M2 polarization to remodel colon cancer immune microenvironment via inhibiting tumor-derived CXCL12

Xuan Jiang et al.

Summary: Triptolide treatment shows therapeutic effects against colon cancer both in vivo and in vitro by inhibiting cancer cell proliferation and inducing apoptosis. In the tumor immune microenvironment, triptolide treatment reduces tumor-associated macrophage infiltration by downregulating tumor-derived CXCL12 expression, thus remodeling the immune microenvironment. Triptolide also inhibits the polarization of colon cancer cells to an anti-inflammatory state, and decreases the migration of cancer cells by reducing vascular endothelial growth factor expression.

JOURNAL OF CELLULAR PHYSIOLOGY (2021)

添加到收藏夹

Article Oncology

HNRNPA2B1 regulates tamoxifen- and fulvestrant-sensitivity and hallmarks of endocrine resistance in breast cancer cells

Belinda J. Petri et al.

Summary: The RNA binding protein and m6A reader HNRNPA2B1 is overexpressed in breast tumors compared to normal tissue. Overexpression of A2B1 leads to tamoxifen and fulvestrant resistance, while knockdown of A2B1 restores endocrine sensitivity. Targeting A2B1 could be a potential therapeutic strategy to overcome acquired endocrine resistance in breast cancer.

CANCER LETTERS (2021)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Prodrug polymeric micelles integrating cancer-associated fibroblasts deactivation and synergistic chemotherapy for gastric cancer

Sheng Zheng et al.

Summary: Triptolide (TPL) has been demonstrated to suppress the activity of cancer-associated fibroblasts (CAFs), reducing CAFs-induced proliferation, migration, and chemotherapy resistance of gastric cancer cells. PSN38@TPL-nsa nanoparticles exhibited potent anti-tumor effects both in vitro and in vivo, showing promise as an effective strategy for treating advanced gastric cancer.

JOURNAL OF NANOBIOTECHNOLOGY (2021)

添加到收藏夹

Article Nanoscience & Nanotechnology

Functional Exosome-Mediated Delivery of Triptolide Endowed with Targeting Properties as Chemotherapy Carriers for Ovarian Carcinoma

Di He et al.

Summary: The exosome-encapsulated triptolide targeted drug delivery system significantly enhances anti-ovarian cancer effects and reduces toxicity, inducing apoptosis of ovarian cancer cells, regulating tumor immunity, and selectively inhibiting tumor-associated macrophages in the tumor microenvironment, showing promise as a treatment for ovarian cancer.

JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2021)

添加到收藏夹

Letter Oncology

HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA

Fengjie Jiang et al.

Summary: This study identified that HNRNPA2B1 is upregulated in multiple myeloma (MM) patients and negatively correlated with prognosis, playing a role in regulating cell proliferation by modulating AKT3 expression. This suggests that HNRNPA2B1 may act as a potential therapeutic target for MM through the ILF3-dependent pattern.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Terpenoids' anti-cancer effects: focus on autophagy

Chirine El-Baba et al.

Summary: Terpenoids, the largest class of natural products derived mainly from plants, exhibit diverse anti-tumor effects, including anti-proliferative, apoptotic, anti-angiogenic, and anti-metastatic activities. The complex relationship between apoptosis and autophagy in cancer cells is driven by a delicate balance of protein regulation, leading to different outcomes through interrelated signaling pathways. Further research on autophagy induction by terpenoids may provide insights for novel cancer therapies and more effective treatment regimens.

APOPTOSIS (2021)

添加到收藏夹

Article Oncology

Natural product triptolide induces GSDME-mediated pyroptosis in head and neck cancer through suppressing mitochondrial hexokinase-ΙΙ

Jing Cai et al.

Summary: The study reveals that triptolide eliminates head and neck cancer cells through inducing GSDME-mediated pyroptosis, and this effect is achieved by inhibiting HK-II and promoting caspase 3 activation. Combination with the SLC7A11 inhibitor erastin shows a strong synergistic effect in suppressing tumor survival in vitro and in a nude mice model. This research provides new insights into the use of TPL in cancer therapy.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Novel CD44-targeting and pH/redox-dual-stimuli-responsive core-shell nanoparticles loading triptolide combats breast cancer growth and lung metastasis

Jinfeng Shi et al.

Summary: The study demonstrates that TPL/NPs, with active targeting to CD44, pH/redox-responsive drug release, and proapoptotic and antimobility effects, show higher efficacy in inhibiting breast cancer proliferation and lung metastasis, while minimizing systemic toxicity.

JOURNAL OF NANOBIOTECHNOLOGY (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Membrane protein-chimeric liposome-mediated delivery of triptolide for targeted hepatocellular carcinoma therapy

Yanwen Zheng et al.

Summary: Triptolide is a diterpenoid triepoxide with broad antitumor efficacy, but limited by lack of mechanism of action, toxicity, and poor solubility. This study successfully enhanced its anticancer efficacy against hepatocellular carcinoma and mitigated toxicity through drug delivery system design and molecular mechanism exploration.

DRUG DELIVERY (2021)

添加到收藏夹

Article Oncology

Thermal Proteome Profiling Identifies Oxidative-Dependent Inhibition of the Transcription of Major Oncogenes as a New Therapeutic Mechanism for Select Anticancer Compounds

Sylvain Peuget et al.

CANCER RESEARCH (2020)

添加到收藏夹

Article Engineering, Biomedical

Sequential delivery of nanoformulated α-mangostin and triptolide overcomes permeation obstacles and improves therapeutic effects in pancreatic cancer

Jingxian Feng et al.

BIOMATERIALS (2020)

添加到收藏夹

Article Oncology

Loss of hnRNPA2B1 inhibits malignant capability and promotes apoptosis via down-regulating Lin28B expression in ovarian cancer

Yu Yang et al.

CANCER LETTERS (2020)

添加到收藏夹

Article Chemistry, Analytical

Microparticle-Assisted Precipitation Screening Method for Robust Drug Target Identification

Jiawen Lyu et al.

ANALYTICAL CHEMISTRY (2020)

添加到收藏夹

Article Medicine, Research & Experimental

The HNRNPA2B1-MST1R-Akt axis contributes to epithelial-to-mesenchymal transition in head and neck cancer

Amit Gupta et al.

LABORATORY INVESTIGATION (2020)

添加到收藏夹

Article Cell Biology

Combining triptolide with ABT-199 is effective against acute myeloid leukemia through reciprocal regulation of Bcl-2 family proteins and activation of the intrinsic apoptotic pathway

Yuan-Fei Shi et al.

CELL DEATH & DISEASE (2020)

添加到收藏夹

Article Oncology

Triptolide targets super-enhancer networks in pancreatic cancer cells and cancer-associated fibroblasts

Pawan Noel et al.

ONCOGENESIS (2020)

添加到收藏夹

Article Oncology

Inhibition of RNA polymerase III transcription by Triptolide attenuates colorectal tumorigenesis

Xia Liang et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)

添加到收藏夹

Article Biochemical Research Methods

Nonparametric Analysis of Thermal Proteome Profiles Reveals Novel Drug-binding Proteins

Dorothee Childs et al.

MOLECULAR & CELLULAR PROTEOMICS (2019)

添加到收藏夹

Article Medicine, Research & Experimental

Triptolide Inhibits the AR Signaling Pathway to Suppress the Proliferation of Enzalutamide Resistant Prostate Cancer Cells

Yangyang Han et al.

THERANOSTICS (2017)

添加到收藏夹

Article Biochemical Research Methods

Thermal proteome profiling for unbiased identification of direct and indirect drug targets using multiplexed quantitative mass spectrometry

Holger Franken et al.

NATURE PROTOCOLS (2015)

添加到收藏夹

Article Biochemistry & Molecular Biology

GD3 synthase regulates epithelial-mesenchymal transition and metastasis in breast cancer

T. R. Sarkar et al.

ONCOGENE (2015)

添加到收藏夹

Article Chemistry, Multidisciplinary

pH-Sensitive Nanoformulated Triptolide as a Targeted Therapeutic Strategy for Hepatocellular Carcinoma

Daishun Ling et al.

ACS NANO (2014)

添加到收藏夹

Article Biochemistry & Molecular Biology

TAB1: A Target of Triptolide in Macrophages

Yan Lu et al.

CHEMISTRY & BIOLOGY (2014)

添加到收藏夹

Review Immunology

Triptolide and its expanding multiple pharmacological functions

Qiuyan Liu

INTERNATIONAL IMMUNOPHARMACOLOGY (2011)

添加到收藏夹

Article Biochemistry & Molecular Biology

XPB, a subunit of TFIIH, is a target of the natural product triptolide

Denis V. Titov et al.

NATURE CHEMICAL BIOLOGY (2011)

添加到收藏夹

Article Biochemistry & Molecular Biology

Cancer-specific enhancement of cisplatin-induced cytotoxicity with triptolide through an interaction of inactivated glycogen synthase kinase-3β with p53

Y. Matsui et al.

ONCOGENE (2008)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.